Search for Clinical Trial Results

Sponsored By

Lymphoma, Extranodal NK-T-Cell - 15 Studies Found

Status Study
Completed Study Name: MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma
Condition: Extranodal NK-T-Cell Lymphoma, Nasal Type
Date: 2016-04-29
Interventions:
  • Drug: MEDA

Completed Study Name: GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma
Condition: Extranodal NK-T-Cell Lymphoma, Nasal Type
Date: 2016-04-05
Interventions:
  • Drug: GELAD Gemcitabine, 1.0g/
Completed Study Name: PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma
Condition: Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Date: 2014-03-11
Interventions:
  • Drug: pegaspargase pegaspargas
Completed Study Name: Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma
Condition: Peripheral T/NK-cell Lymphoma
Date: 2010-08-30
Interventions: Biological: KW-0761 Intravenously 8 times at 1-week intervals
Active, not recruiting Study Name: Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Condition: Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Date: 2015-09-11
Interventions:
  • Other: chemotherapy followed by radiotherapy
<<< Previous